Estados financieros detallados de Nautilus Biotechnolgy, Inc. (NAUT): cuenta de resultados, balance general y flujo de caja. Sigue la evolución de márgenes, deuda, liquidez y rentabilidad año a año con hasta 20 años de histórico.
Resumen del Análisis
Márgenes de los últimos 12 meses: margen bruto -9.2%, margen operativo -330.4%, margen neto -297.5%.
Al precio actual de $0.97, NAUT presenta beneficios negativos (P/E no significativo) y un ROE del -37.58%. La capitalización bursátil es de $124M.
Cuenta de Resultados (10 años)
| Año | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Ingresos | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Coste de Ventas | 0 | 0 | $2.3M | $2.8M | 0 | $5.7M | $6.4M | $6.5M |
| Beneficio Bruto | 0 | 0 | -$2.3M | -$2.8M | 0 | -$5.7M | -$6.4M | -$6.5M |
| I+D | 0 | $8.5M | $10.1M | $26.5M | $37.7M | $47.3M | $50.5M | $41.1M |
| Generales y Administrativos | $111.7M | $1.6M | $3.3M | $21.1M | $25.9M | $28.9M | $31.0M | $25.7M |
| Gastos Operativos | $111.7M | $10.1M | $13.4M | $47.7M | $63.6M | $70.4M | $75.1M | $60.4M |
| Beneficio Operativo | -$111.7M | -$10.1M | -$15.7M | -$50.5M | -$63.6M | -$76.2M | -$81.5M | -$66.8M |
| EBITDA | $626.6M | -$9.6M | -$13.3M | -$47.5M | -$60.1M | -$61.8M | -$64.4M | -$52.5M |
| Gastos por Intereses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Beneficio Antes de Impuestos | $626.6M | -$9.6M | -$15.6M | -$50.3M | -$57.9M | -$63.7M | -$70.8M | -$59.0M |
| Impuestos | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Beneficio Neto | $626.6M | -$9.6M | -$15.6M | -$50.3M | -$57.9M | -$63.7M | -$70.8M | -$59.0M |
| BPA | $87.18 | $-1.59 | $-0.47 | $-0.60 | $-0.46 | $-0.51 | $-0.56 | $-0.47 |
| BPA Diluido | $87.18 | $-1.59 | $-0.47 | $-0.60 | $-0.46 | $-0.51 | $-0.56 | $-0.47 |
| Acciones en Circulación (Diluidas) | $7.2M | $6.1M | $33.1M | $84.5M | $124.6M | $124.9M | $125.4M | $126.3M |
Cuenta de Resultados (Trimestral)
| Año | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|
| Ingresos | 0 | 0 | 0 | $190000 |
| Beneficio Bruto | 0 | -$1.6M | -$1.5M | $1.3M |
| Beneficio Operativo | -$15.5M | -$15.4M | -$16.1M | -$15.8M |
| EBITDA | -$13.8M | -$12.2M | -$13.2M | -$15.8M |
| Beneficio Neto | -$13.6M | -$13.8M | -$14.7M | -$14.5M |
| BPA | $-0.11 | $-0.11 | $-0.12 | $-0.11 |
| BPA Diluido | $-0.11 | $-0.11 | $-0.12 | $-0.11 |
Balance (10 años)
| Año | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Caja y Equivalentes | $1.2M | $595000 | $36.6M | $185.6M | $114.5M | $19.4M | $27.6M | $12.4M |
| Inversiones a Corto | $144.49B | $16.1M | $40.1M | $160.1M | $69.9M | $154.0M | $102.2M | $91.0M |
| Cuentas por Cobrar | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Inventario | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Corrientes | $1.3M | $17.0M | $77.7M | $349.2M | $187.2M | $176.8M | $132.8M | $106.0M |
| Inmovilizado Material | 0 | $1.1M | $6.2M | $31.9M | $32.6M | $36.9M | $32.3M | $31.2M |
| Fondo de Comercio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Intangibles | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Totales | $145.8M | $18.5M | $85.0M | $398.4M | $350.1M | $305.6M | $242.7M | $191.1M |
| Cuentas por Pagar | 0 | $289000 | $470000 | $1.7M | $1.3M | $1.6M | $987000 | $943000 |
| Deuda a Corto | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Pasivos Corrientes | $5000 | $490000 | $3.0M | $5.8M | $6.8M | $9.1M | $7.6M | $8.0M |
| Deuda a Largo | $5.0M | $275.0M | 0 | 0 | 0 | 0 | 0 | 0 |
| Pasivos Totales | $140.8M | $490000 | $114.7M | $34.9M | $35.1M | $40.2M | $34.0M | $34.1M |
| Reservas | $626600 | -$14.7M | -$30.3M | -$80.6M | -$138.6M | -$202.2M | -$273.0M | -$332.0M |
| Patrimonio Neto | $5.0M | $18.1M | -$29.7M | $363.6M | $314.9M | $265.4M | $208.7M | $157.0M |
| Deuda Total | $5.0M | $275.0M | $4.8M | $30.0M | $30.3M | $34.6M | $30.5M | $30.0M |
| Deuda Neta | -$144.48B | $258.3M | -$72.0M | -$315.7M | -$154.1M | -$138.8M | -$99.4M | -$73.4M |
| Capital Circulante | $1.3M | $16.5M | $74.6M | $343.4M | $180.4M | $167.7M | $125.2M | $98.0M |
Balance (Trimestral)
| Año | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|
| Caja y Equivalentes | $23.9M | $12.4M | $14.6M | $13.2M |
| Activos Totales | $200.9M | $191.1M | $177.8M | $163.6M |
| Pasivos Totales | $31.8M | $34.1M | $33.4M | $32.5M |
| Patrimonio Neto | $169.1M | $157.0M | $144.4M | $131.1M |
| Deuda Total | $27.0M | $30.0M | $28.9M | $27.8M |
Flujo de Caja (10 años)
| Año | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Beneficio Neto | $626.6M | -$9.6M | -$15.6M | -$50.3M | -$57.9M | -$63.7M | -$70.8M | -$59.0M |
| Amortizaciones | 0 | $548000 | $2.3M | $2.8M | $3.4M | $5.7M | $6.4M | $6.5M |
| Compensación en Acciones | 0 | $110000 | $369000 | $7.9M | $10.4M | $12.1M | $12.7M | $6.8M |
| Cambio en Capital Circulante | $1.3M | -$545000 | -$1.4M | -$22000 | -$788000 | -$3.2M | -$5.5M | -$3.6M |
| Flujo de Caja Operativo | -$238.3M | -$9.7M | -$14.0M | -$39.2M | -$45.8M | -$51.7M | -$59.1M | -$50.7M |
| Inversiones (CapEx) | 0 | -$926000 | -$921000 | -$2.3M | -$2.3M | -$2.4M | -$2.1M | -$1.3M |
| Adquisiciones | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Recompra de Acciones | -$1.2M | -$874326 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividendos Pagados | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Flujo de Caja Libre | -$238.3M | -$10.6M | -$14.9M | -$41.5M | -$48.1M | -$54.2M | -$61.3M | -$52.0M |
Flujo de Caja (Trimestral)
| Año | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|
| Flujo de Caja Operativo | -$11.0M | -$12.4M | -$13.1M | -$13.7M |
| Inversiones (CapEx) | -$418000 | -$244000 | -$510000 | -$454000 |
| Flujo de Caja Libre | -$11.5M | -$12.6M | -$13.6M | -$14.2M |
| Dividendos Pagados | 0 | 0 | 0 | 0 |
| Compensación en Acciones | $1.5M | $1.5M | $1.4M | $1.2M |
Crecimiento y Márgenes (10 años)
| Año | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Crecimiento Beneficio Neto (anual) | | -101.5% | -62.4% | -222.1% | -15.1% | -9.9% | -11.2% | +16.6% |
| Crecimiento BPA (anual) | | -101.8% | +70.4% | -27.7% | +23.3% | -10.9% | -9.8% | +16.1% |
| Cambio en Acciones (anual) | | -15.6% | +445.1% | +155.4% | +47.5% | +0.3% | +0.4% | +0.7% |
| Crecimiento FCF (anual) | | +95.6% | -40.9% | -178.3% | -15.9% | -12.5% | -13.1% | +15.2% |
| Tasa Impositiva Efectiva | 0.0% | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% |
Datos por Acción (10 años)
| Año | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| FCF por Acción | $-33.15 | $-1.75 | $-0.45 | $-0.49 | $-0.39 | $-0.43 | $-0.49 | $-0.41 |
| Dividendo por Acción | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Acciones en Circulación (Básicas) | $7.2M | $6.1M | $33.1M | $84.5M | $124.6M | $124.9M | $125.4M | $126.3M |
Qué mirar en Biotech
La mayoría de biotechs pequeñas pierden dinero. Analizarlas con P/E no tiene sentido — mira caja y pipeline.
- Cash Runway — Meses de caja al ritmo de gasto actual. <18 meses = riesgo de dilución urgente
- Cash burn anual — Ritmo al que queman caja operativa. Comparar con posición de caja para proyectar runway
- Total Debt — Biotech sin ingresos + deuda = receta para bancarrota
- I+D / Capitalización — Cuánto invierten en pipeline vs lo que vale la empresa — indicador de intensidad investigadora
- Market cap / Cash — Si cotiza cerca de su caja, el mercado le da ~0 valor al pipeline — puede ser oportunidad o trampa
Rentabilidad
| Rentabilidad sobre capital | -37.58% |
| Rentabilidad sobre capital invertido | -39.50% |
| Rentabilidad sobre activos | -34.55% |
| Margen bruto | -919.47% |
| Margen operativo | -33043.68% |
| Margen neto | -29747.89% |
Salud financiera
| Deuda / Patrimonio | 0.21 |
| Ratio corriente | 10.14 |
Ratios Clave (10 años)
| Año | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| P/E | 0.12 | -6.57 | -23.09 | -8.63 | -3.91 | -5.86 | -3.00 | -4.15 |
| P/VC | 15.01 | 3.51 | -12.07 | 1.20 | 0.71 | 1.41 | 1.01 | 1.57 |
| P/V | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Margen Bruto | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Margen Operativo | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Margen Neto | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |